Part 1
FDA’s Cara Welch on RRAs & third-party audits: 'We’re staring at a backlog of inspections'
The head of the FDA’s Office of Dietary Supplement Programs suspects that remote regulatory assessments (RRAs) will continue even as regular facility inspections resume post-COVID, as the agency seeks to get a good picture of the compliance status of...